Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
European Journal of Endocrinology
|
April 17, 2019
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence
A Calabrese, V Basile, S Puglisi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2006
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
P Ceppi, M Volante, S Novello, et al.
Journal of Chromatography. A
|
April 7, 1998
Inter-laboratory validation of solid-phase microextraction for the determination of triazine herbicides and their degradation products at ng/l level in water samples
R Ferrari, T Nilsson, R Arena, et al.
Free Radical Biology & Medicine
|
March 27, 2019
Increased production of 27-hydroxycholesterol in human colorectal cancer advanced stage: Possible contribution to cancer cell survival and infiltration
D Rossin, I H K Dias, M Solej, et al.
European Journal of Endocrinology
|
May 25, 2013
Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection
M Terzolo, A E Baudin, A Ardito, et al.
Endocrine-Related Cancer
|
December 18, 2013
Grading the neuroendocrine tumors of the lung: an evidence-based proposal
G Rindi, C Klersy, F Inzani, et al.
ESMO Open
|
December 24, 2021
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities
M Simbolo, G Centonze, G Ali, et al.
Endocrine-Related Cancer
|
July 16, 2020
The IGF2 methylation score for adrenocortical cancer: an ENSAT validation study
S G Creemers, R A Feelders, N Valdes, et al.
Endocrine-Related Cancer
|
October 5, 2007
DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients
Y M H Jonkers, S M H Claessen, A Perren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 23, 2015
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
R Libé, I Borget, C L Ronchi, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
European Journal of Endocrinology
|
April 17, 2019
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence
A Calabrese, V Basile, S Puglisi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2006
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
P Ceppi, M Volante, S Novello, et al.
Journal of Chromatography. A
|
April 7, 1998
Inter-laboratory validation of solid-phase microextraction for the determination of triazine herbicides and their degradation products at ng/l level in water samples
R Ferrari, T Nilsson, R Arena, et al.
Free Radical Biology & Medicine
|
March 27, 2019
Increased production of 27-hydroxycholesterol in human colorectal cancer advanced stage: Possible contribution to cancer cell survival and infiltration
D Rossin, I H K Dias, M Solej, et al.
European Journal of Endocrinology
|
May 25, 2013
Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection
M Terzolo, A E Baudin, A Ardito, et al.
Endocrine-Related Cancer
|
December 18, 2013
Grading the neuroendocrine tumors of the lung: an evidence-based proposal
G Rindi, C Klersy, F Inzani, et al.
ESMO Open
|
December 24, 2021
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities
M Simbolo, G Centonze, G Ali, et al.
Endocrine-Related Cancer
|
July 16, 2020
The IGF2 methylation score for adrenocortical cancer: an ENSAT validation study
S G Creemers, R A Feelders, N Valdes, et al.
Endocrine-Related Cancer
|
October 5, 2007
DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients
Y M H Jonkers, S M H Claessen, A Perren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 23, 2015
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
R Libé, I Borget, C L Ronchi, et al.
Page
of 8